Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optamox in Postoperative Acute Cholecystitis
NCT02057679Phase 4Completed
- Sponsor
- Hospital Italiano de Buenos Aires
- Start
- Feb 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amoxicillin clavulanate in acute cholecystitis, sponsored by Hospital Italiano de Buenos Aires. Primary endpoint: Incidence of infectious postoperative complications at 30 days. Started Feb 2014; status: completed.
02
Drugs
amoxicillin clavulanate
03
Conditions
acute cholecystitis
Beyond the preview
Go deeper on NCT02057679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057679.